EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Study of the Mechanism of Astragali Radix in Treating Type 2 Diabetes Mellitus and Its Renal Protection Based on Enzyme Activity, Network Pharmacology, and Experimental Verification

Chunnan Li iD, Kaiyue Zhang, Lu Liu, Jiaming Shen, Yuelong Wang, Yiying Tan, Xueqin Feng, Wanjie Liu, Hui Zhang, Jiaming Sun

Molecules · 2023

DOI: 10.3390/molecules28248030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Chunnan Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun 130117, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Astragalus Plant, Drugs, Chinese Herbal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Province Science and Technology Department, Project supported by postdoctoral researchers in Jilin Province, Young Scientist Program of "XingLin Scholar Project" of Changchun University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Astragali Radix (AR) is a common Chinese medicine and food. This article aims to reveal the active role of AR in treating Type 2 diabetes mellitus (T2DM) and its renal protective mechanism. The hypoglycemic active fraction was screened by α-glucosidase and identified by UPLC-QE-Orbitrap-MS spectrometry. The targets and KEGG pathway were determined through the application of network pharmacology methodology. Molecular docking and molecular dynamics simulation technology were used for virtual verification. Subsequently, a mouse model of T2DM was established, and the blood glucose and renal function indexes of the mice after administration were analyzed to further prove the pharmacodynamic effect and mechanism of AR in the treatment of T2DM. HA was determined as the best hypoglycemic active fraction by the α-glucosidase method, with a total of 23 compounds identified. The main active components, such as calycoside-7-O-β-D-glucoside, methylnisoline, and formononetin, were revealed by network pharmacology. In addition, the core targets and the pathway have also been determined. Molecular docking and molecular dynamics simulation techniques have verified that components and targets can be well combined. In vivo studies have shown that AR can reduce blood sugar levels in model mice, enhance the anti-inflammatory and antioxidant activities of kidney tissue, and alleviate kidney damage in mice. And it also has regulatory effects on proteins such as RAGE, PI3K, and AKT. AR has a good therapeutic effect on T2DM and can repair disease-induced renal injury by regulating the RAGE/PI3K/Akt signaling pathway. This study provides ideas for the development of new drugs or dietary interventions for the treatment of T2DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Astragalus PlantDrugs, Chinese HerbalAnimalsMiceMolecular Docking SimulationNetwork PharmacologyPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktalpha-GlucosidasesKidneyHypoglycemic Agents

Stichwörter der Autor:innen

Astragali RadixT2DMUPLC-QE-Orbitrap-MSmechanismnetwork pharmacology

Substanzen

Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktalpha-GlucosidasesHypoglycemic AgentsDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun 130117, China.
  • Jilin Correction Pharmacy New Drug Development Co., Ltd., Changchun 130012, China.

ORCID-Profile: Chunnan Li

Förderung

  • Jilin Province Science and Technology Department
  • Project supported by postdoctoral researchers in Jilin Province
  • Young Scientist Program of "XingLin Scholar Project" of Changchun University of Chinese Medicine
  • postdoctoral researchers in Jilin Province
  • Young Scientist Program of “XingLin Scholar Project” of Changchun University of Chinese Medicine

Zitieren

APA

Li, C., Zhang, K., Liu, L., Shen, J., Wang, Y., Tan, Y., Feng, X., Liu, W., Zhang, H., & Sun, J. (2023). Study of the Mechanism of Astragali Radix in Treating Type 2 Diabetes Mellitus and Its Renal Protection Based on Enzyme Activity, Network Pharmacology, and Experimental Verification. Molecules. https://doi.org/10.3390/molecules28248030

Vancouver

Li C, Zhang K, Liu L, Shen J, Wang Y, Tan Y, et al. Study of the Mechanism of Astragali Radix in Treating Type 2 Diabetes Mellitus and Its Renal Protection Based on Enzyme Activity, Network Pharmacology, and Experimental Verification. Molecules. 2023. doi:10.3390/molecules28248030

BibTeX
@article{Li2023,
  author = {Li, Chunnan and Zhang, Kaiyue and Liu, Lu and Shen, Jiaming and Wang, Yuelong and Tan, Yiying and Feng, Xueqin and Liu, Wanjie and Zhang, Hui and Sun, Jiaming},
  title = {Study of the Mechanism of Astragali Radix in Treating Type 2 Diabetes Mellitus and Its Renal Protection Based on Enzyme Activity, Network Pharmacology, and Experimental Verification},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28248030}
}
Kostenlos starten →